Compare NPKI & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPKI | SDGR |
|---|---|---|
| Founded | 1932 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1995 | 2020 |
| Metric | NPKI | SDGR |
|---|---|---|
| Price | $13.16 | $19.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $14.17 | ★ $21.00 |
| AVG Volume (30 Days) | 811.9K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 126.16 | 45.14 |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $747,763,000.00 | $255,869,000.00 |
| Revenue This Year | $16.39 | $0.76 |
| Revenue Next Year | $11.70 | $4.60 |
| P/E Ratio | $52.12 | ★ N/A |
| Revenue Growth | ★ 58.59 | 23.29 |
| 52 Week Low | $10.11 | $10.95 |
| 52 Week High | $16.50 | $23.02 |
| Indicator | NPKI | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 62.61 |
| Support Level | $13.34 | $17.23 |
| Resistance Level | $14.86 | $20.48 |
| Average True Range (ATR) | 0.40 | 0.82 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 29.90 | 81.17 |
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.